Wayland Provides Clarification on Recent German Tender Update

April 19, 19

TORONTO, April 18, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to expand on the update that the Company provided to the market on April 17, 2019 with respect to the ongoing process for domestic cultivation of medical cannabis in Germany (“the Update”). The Company would like

Read More

Wayland Provides Update on German Tender Process

April 17, 19

TORONTO, ON, April 17, 2019 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Earlier today, the German Federal Institute for Drugs and Medical Devices (“BfArM”) announced that 9 of the 13 cultivation

Read More

Wayland Group Announces Facility Drawdown

April 15, 19

TORONTO, April 12, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the fifth facility under its previously-announced subscription agreement with Alpha Blue and has issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of

Read More

Wayland Group Announces Changes to the Board of Directors

April 10, 19

TORONTO, ON, April 9, 2019 – Wayland Group Corp. (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announces the following change to its Board of Directors. Due to personal reasons, Rudi Hilti has resigned as Director of Wayland Group Corp. Mr. Hilti’s responsibilities at his own commercial and non-commercial enterprises have increased to a level

Read More

Wayland Selected as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany

April 04, 19

TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is excited to announce that the Company has been selected by the German Federal Institute for Drugs and Medical Devices (“BfArM”), through its German joint venture DEMECAN GmbH, to begin domestic production of medical cannabis for the rapidly

Read More

Wayland Group Announces Facility Drawdown

March 23, 19

TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the third facility under its previously-announced subscription agreement with Alpha Blue and has issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of

Read More

Wayland Group Announces Facility Drawdown

March 15, 19

TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) today announced that it has completed the drawdown of the second facility under its previously-announced subscription agreement with Alpha Blue and issued the corresponding Convertible Debenture and Facility Warrants. Please refer to the Company’s news release of February

Read More

Wayland Group announces Corporate Update

March 11, 19

TORONTO, March 11, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce it is near completion of its due diligence of International Cannabis Corp (ICC). Wayland group is pleased to announce it is near completion of its due diligence of International Cannabis Corp. (ICC) and is

Read More

Wayland Group Provides Corporate Update

February 20, 19

TORONTO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce a corporate update on its operational progress in Canada and internationally. Langton Production Facilities The Company is now completing a third harvest at its new facility in Langton, ON, Canada, with licenses for cultivation

Read More

Wayland Group Receives EU-GMP Certification for German Facility

February 07, 19

TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that it has received both Good Manufacturing Practices and Good Distribution Practices certifications from the national authority in the State of Saxony for the Company’s Ebersbach facility in Germany. Specifically, these certifications are for a

Read More